Why Was IGF-1 LR3 Designed for an Extended Half-Life?

Native IGF-1's biological role depends on tight IGFBP regulation — this is a feature, not a flaw, of normal human physiology, since it controls how much IGF-1 signal reaches tissues at any given time. For researchers studying IGF-1 receptor biology in isolation, however, that same regulation becomes an obstacle: native IGF-1 added to a cell-culture system is quickly sequestered by IGFBPs, shortening the window during which it can meaningfully activate the receptor.

The Long Arg3 modification addresses this specific research problem by reducing IGFBP affinity without altering the receptor-binding region of the molecule, based on published structural and binding studies. The result is a research reagent that produces more sustained IGF-1 receptor engagement in laboratory settings than native IGF-1 does — which is the entire functional rationale behind IGF-1 LR3's development, not a claim about its effects in the human body.

This explanation covers the research design rationale for the molecule only. It does not describe or imply any dosing, administration, or usage protocol, and REVIVE LAB UAE does not sell IGF-1 LR3.